Patrícia Marques‐Alves

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Going beyond classic echo in aortic stenosis: left atrial mechanics, a new marker of severity

Patrícia Marques‐Alves, Ana Vera Marinho, Rogério Teixeira et al. · BMC Cardiovascular Disorders · 2019 · 24 citations · Full text

Classic Echo, Heart Failure, Diastolic Function +19

Two-dimensional speckle-tracking global longitudinal strain in high-sensitivity troponin-negative low-risk patients with unstable angina: a “resting ischemia test”?

Patrícia Marques‐Alves, Nuno Espírito-Santo, Rui Baptista et al. · International journal of cardiac imaging · 2017 · 18 citations

Vascular Image, Health Sciences, Cardiovascular Disease +11

Left atrial mechanics in moderate mitral valve disease: earlier markers of damage

Patrícia Marques‐Alves, Ana Vera Marinho, C Domingues et al. · International journal of cardiac imaging · 2019 · 15 citations

Heart Failure, Structural Heart Disease, Cardiovascular Disease +10